Milestone Scientific Inc (NYSE:MLSS) said that, following a successful trial, it has signed an agreement for the purchase of its CompuFlo Epidural and CathCheck Verification System disposables with a major Northeast teaching hospital.
“We are honored to announce the adoption of our CompuFlo Epidural and CathCheck Verification System by yet another important and prestigious hospital,” said Arjan Haverhals, CEO of Milestone Scientific in a statement.
He added: “This approval follows an extensive trial, which further validates the safety and efficacy of our technology. As a teaching hospital, our tools provide residents, fellows, and even seasoned physicians greater accuracy through real-time verification of epidural needle placement, as well as subsequent monitoring of catheter placement.”
READ: Milestone Scientific says recognized pain management expert Dr Miguel de la Garza has adopted its CompuFlo Epidural instrument
The CompuFlo Epidural instrument has the potential to significantly reduce costs associated with morbidity, providing a direct economic benefit to healthcare institutions. Similarly, the CathCheck Verification System technology has the potential to transform the monitoring of catheter placement following an epidural procedure by confirming the placement of a catheter within two minutes, versus the 20 to 40 minutes using conventional methods.
“While our initial rollout is focused on the labor and delivery market, we are also targeting the pain management sector. Their network not only includes numerous hospitals, but also specialty centers, outpatient centers, and sports medicine centers,” Haverhals said.
The New Jersey-based company said that the clinical and safety benefits of the CompuFlo Epidural and CathCheck Verification Systems are backed by extensive published clinical data demonstrating significant reductions in epidural punctures, as well as complication rates, and contribute to a significant savings of time on the part of anesthesiologists.
Milestone Scientific, a technology-focused medical research and development company that patents, designs and develops innovative injection technologies and instruments for medical, dental, and cosmetic applications.
Contact Ritika at ritika@proactiveinvestors.com